|
Sl No
|
Name of the Project
|
Date of Inception
|
Date of Conclusion
|
Objective of the Study
|
Achievement
|
|
1
|
Clinical Verification Study on 8 drugs
|
4th December 2018
|
15th November 2022
|
To evolve clinically verified complete pathogenesis of the 8 drugs under study.
Additional symptoms, which respond to the respective drugs.
Clinical symptoms (which were not observed during proving but seen to have disappeared in the sick during the study).
|
Screening – 765
Enrolment – 388
|
|
2
|
Concurrent Drug utilization evaluation including medication adherence of Arsenicum album 30 as prophylactic medicine and immunity booster against COVID-19: a descriptive, cross-sectional research study
|
01.10.2023
|
17.10.2023
|
To assess the drug utilization including medication adherence, compliance and persistence of Homoeopathic prophylactic medicine Arsenicum album 30 on general population.
|
Total Screened- 1002
Total Enrolled- 1002
|
|
3
|
Clinical Profiling of COVID-19 Patients during the Third Wave
|
January 2022
|
March 2022
|
1) Systematic characterization of the clinical presentation of COVID-19 patients during the third wave of COVID-19 pandemic in India
2) Identification of commonly prescribed homeopathic medicines/prescribing patterns.
3) Gather information about previous vaccination status, previous COVID-19 infection
|
COVID-19 patients screened- 1329
COVID-19 patients enrolled- 82
|
|
4
|
Experience, Perception and Prescription habits of Indian Homoeopathic Physicians in the treatment of diabetes Mellitus: An Online Observational Study
|
10.07.2021
|
18.08.2021
|
To assess the prescription habits, experience and perception of Indian Homoeopathic practitioners in cases of DM.
|
Responses received – 537
Responses analyzed – 513
|
|
5
|
Disease Characteristics, Care-Seeking Behavior, and Outcomes Associated with the Use of AYUSH-64 in COVID-19 Patients in Home Isolation in India: A Community-Based Cross-Sectional Analysis
|
June 2021
|
30.08.2021
|
1) To identify and establish AYUSH-64 as a potential adjunct to standard care.
2) To help in clinical recovery and improvement in the quality of life of the subjects who are in home isolation.
3) To study the profile of COVID-19 patients who are receiving AYUSH-64
|
Patients benefited- 465
Tablets distributed–52,000
|
|
6
|
Vithoulkas Compass (VC) Study
|
18.12.2018
|
January 2021
|
To improve repertory and materia medica based on statistical analysis of real-time information provided by the end users– theprescribers
|
Enrolled– 683
|
|
7
|
Association between prophylactic Ayush interventions and disease outcome in COVID-19 positive patients: a retrospective cohort study
|
05.10.2020
|
11.11.2020
|
To observe the level of awareness and usage of AYUSH prophylaxis in recovered COVID-19 positive patients.
|
Screened– 265
Enrolled– 153
|
|
8
|
Patient Reported Outcome Measure (PROM) Study
|
02.01.2018
|
15.10.2020
|
To assess what sort of chronic patients are being treated
- To assess the overall outcomes through patient reported
outcome measures
- To see whether the introduction of homoeopathy enabled a
reduction in conventional medication (if any)
To assess the overall quality of life
|
Enrolled– 392
|
|
9
|
Lifestyle disorder (LSD) Clinic
|
16.01.2019
|
15.09.2020
|
To prevent and promote and also to treat the life style therapy including yoga in Pre-clinical conditions (Pre Diabetes. Pre hypertension and Borderline high risk lipid levels).
|
Numbers of cases attended- 844
Enrolled- 193
|
|
10
|
Clinical Verification Study on 16 drugs
|
May 2014
|
September 2018
|
To evolve clinically verified complete pathogenesis of the 16 drugs under study.
Additional symptoms, which respond to the respective drugs.
Clinical symptoms (which were not observed during proving but seen to have disappeared in the sick during the study).
|
Total Research Case– 320
|
|
11
|
Drug Validation Study (Hemorrhoids)
|
10.11.2015
|
31.08.2018
|
To observe change in severity of Sodergren score at the end of 6 months of treatment and to observe change in WHO QoL assessment scale
|
Screening– 210
Enrollment– 60
|
|
12
|
Effects of individualized homoeopathic intervention in Stage 1 essential hypertension: A single-blind, randomized, placebo-controlled trial
|
13.11.2013
|
December, 2017
|
Effects of Homoeopathic intervention in stage 1 essential hypertensive Patients
|
Beneficiary- 243
|
|
13
|
Clinical Verification Study on 23 drugs
|
June2010
|
September 2014
|
To evolve clinically verified complete pathogenesis of the 23 drugs under study.
Additional symptoms, which respond to the respective drugs.
Clinical symptoms (which were not observed during proving but seen to have disappeared in the sick during the study)
|
Screening-1049
Enrolment– 852
Improved– 774
|